145 related articles for article (PubMed ID: 31415427)
41. The effect of guideline-concordant care in mitigating insurance status disparities in cervical cancer.
Wu J; Huang Y; Tergas AI; Melamed A; Khoury-Collado F; Hou JY; St Clair CM; Ananth CV; Hershman DL; Wright JD
Gynecol Oncol; 2020 Nov; 159(2):309-316. PubMed ID: 32800656
[TBL] [Abstract][Full Text] [Related]
42. Socioeconomic and Racial Determinants of Brachytherapy Utilization for Cervical Cancer: Concerns for Widening Disparities.
Boyce-Fappiano D; Nguyen KA; Gjyshi O; Manzar G; Abana CO; Klopp AH; Kamrava M; Orio PF; Thaker NG; Mourtada F; Venkat P; Chang AJ
JCO Oncol Pract; 2021 Dec; 17(12):e1958-e1967. PubMed ID: 34550749
[TBL] [Abstract][Full Text] [Related]
43. Feasibility study of toxicity outcomes using GEC-ESTRO contouring guidelines on CT based instead of MRI-based planning in locally advanced cervical cancer patients.
Koh V; Choo BA; Lee KM; Tan TH; Low JH; Ng SY; Ilancheran A; Shen L; Tang J
Brachytherapy; 2017; 16(1):126-132. PubMed ID: 27816539
[TBL] [Abstract][Full Text] [Related]
44. Guideline-concordant Care Improves Overall Survival for Locally Advanced Non-Small-cell Lung Carcinoma Patients: A National Cancer Database Analysis.
Ahmed HZ; Liu Y; O'Connell K; Ahmed MZ; Cassidy RJ; Gillespie TW; Patel P; Pillai RN; Behera M; Steuer CE; Owonikoko TK; Ramalingam SS; Curran WJ; Higgins KA
Clin Lung Cancer; 2017 Nov; 18(6):706-718. PubMed ID: 28601387
[TBL] [Abstract][Full Text] [Related]
45. Clinical outcomes following conventional external beam radiotherapy boost in Japanese patients with cervical cancer who are ineligible for intracavitary brachytherapy.
Ito K; Shimizuguchi T; Karasawa K
Jpn J Clin Oncol; 2019 Mar; 49(3):270-275. PubMed ID: 30576504
[TBL] [Abstract][Full Text] [Related]
46. Patterns of care with brachytherapy for cervical cancer.
Bagshaw HP; Pappas LM; Kepka DL; Tward JD; Gaffney DK
Int J Gynecol Cancer; 2014 Nov; 24(9):1659-64. PubMed ID: 25251463
[TBL] [Abstract][Full Text] [Related]
47. Underserved Pacific Islanders With Locally Advanced Cervical Cancer Receive Higher Rates of Standard-of-Care Radiation Treatment Through the Pacific Island Health Care Project and Military Health System Compared to the Average U.S. Population.
Sitler C; Bunch KP; Padro D; Miller CR
Mil Med; 2023 Mar; 188(3-4):e792-e796. PubMed ID: 34453178
[TBL] [Abstract][Full Text] [Related]
48. [Clinical study of intensity modulated radiotherapy and three-dimensional conformal radiotherapy with three-dimensional brachytherapy and concurrent chemotherapy for patients with advanced cervical cancer].
Du XX; Yang H; Zhang HJ; Li LA; Fan WS; Meng YG
Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):679-686. PubMed ID: 29060966
[No Abstract] [Full Text] [Related]
49. No improvement in survival of older women with cervical cancer-A nationwide study.
Wenzel HHB; Bekkers RLM; Lemmens VEPP; Van der Aa MA; Nijman HW
Eur J Cancer; 2021 Jul; 151():159-167. PubMed ID: 33993062
[TBL] [Abstract][Full Text] [Related]
50. Adenocarcinoma histology is a poor prognostic factor in locally advanced cervical cancer.
Jonska-Gmyrek J; Gmyrek L; Zolciak-Siwinska A; Kowalska M; Kotowicz B
Curr Med Res Opin; 2019 Apr; 35(4):595-601. PubMed ID: 30019594
[TBL] [Abstract][Full Text] [Related]
51. Effect of bladder distension on doses to organs at risk in Pulsed-Dose-Rate 3D image-guided adaptive brachytherapy for locally advanced cervical cancer.
Nesseler JP; Charra-Brunaud C; Salleron J; Py JF; Huertas A; Meknaci E; Courrech F; Peiffert D; Renard-Oldrini S
Brachytherapy; 2017; 16(5):976-980. PubMed ID: 28694116
[TBL] [Abstract][Full Text] [Related]
52. Pattern of Care, Health Care Disparities, and Their Impact on Survival Outcomes in Stage IVB Cervical Cancer: A Nationwide Retrospective Cohort Study.
Jalloul RJ; Sharma S; Tung CS; O'Donnell B; Ludwig M
Int J Gynecol Cancer; 2018 Jun; 28(5):1003-1012. PubMed ID: 29757872
[TBL] [Abstract][Full Text] [Related]
53. Comparison of outcomes for MR-guided versus CT-guided high-dose-rate interstitial brachytherapy in women with locally advanced carcinoma of the cervix.
Kamran SC; Manuel MM; Cho LP; Damato AL; Schmidt EJ; Tempany C; Cormack RA; Viswanathan AN
Gynecol Oncol; 2017 May; 145(2):284-290. PubMed ID: 28318644
[TBL] [Abstract][Full Text] [Related]
54. Improved survival with adjuvant brachytherapy in stage IA endometrial cancer of unfavorable histology.
Shinde A; Li R; Amini A; Chen YJ; Cristea M; Dellinger T; Wang W; Wakabayashi M; Beriwal S; Glaser S
Gynecol Oncol; 2018 Oct; 151(1):82-90. PubMed ID: 30170976
[TBL] [Abstract][Full Text] [Related]
55. High-dose-rate versus low-dose-rate brachytherapy in the treatment of cervical cancer: analysis of tumor recurrence--the University of Wisconsin experience.
Petereit DG; Sarkaria JN; Potter DM; Schink JC
Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1267-74. PubMed ID: 10613322
[TBL] [Abstract][Full Text] [Related]
56. Concurrent chemoradiotherapy incorporating high-dose rate brachytherapy for locally advanced cervical carcinoma: survival outcomes, patterns of failure, and prognostic factors.
Teh J; Yap SP; Tham I; Sethi VK; Chua EJ; Yeo R; Ho TH; Tay EH; Chia YN; Soh LT; Khoo-Tan HS
Int J Gynecol Cancer; 2010 Apr; 20(3):428-33. PubMed ID: 20375809
[TBL] [Abstract][Full Text] [Related]
57. Early clinical outcomes of ultrasound-guided CT-planned high-dose-rate interstitial brachytherapy for primary locally advanced cervical cancer.
Mesko S; Swamy U; Park SJ; Borja L; Wang J; Demanes DJ; Kamrava M
Brachytherapy; 2015; 14(5):626-32. PubMed ID: 26024784
[TBL] [Abstract][Full Text] [Related]
58. Predictors of Radiation Field Failure After Definitive Chemoradiation in Patients With Locally Advanced Cervical Cancer.
Bae HS; Kim YJ; Lim MC; Seo SS; Park SY; Kang S; Kim SH; Kim JY
Int J Gynecol Cancer; 2016 May; 26(4):737-42. PubMed ID: 26937749
[TBL] [Abstract][Full Text] [Related]
59. Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients.
Ribeiro I; Janssen H; De Brabandere M; Nulens A; De Bal D; Vergote I; Van Limbergen E
Radiother Oncol; 2016 Sep; 120(3):447-454. PubMed ID: 27157510
[TBL] [Abstract][Full Text] [Related]
60. Quality indicators for cervical cancer care in Japan.
Watanabe T; Mikami M; Katabuchi H; Kato S; Kaneuchi M; Takahashi M; Nakai H; Nagase S; Niikura H; Mandai M; Hirashima Y; Yanai H; Yamagami W; Kamitani S; Higashi T
J Gynecol Oncol; 2018 Nov; 29(6):e83. PubMed ID: 30207093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]